Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Debt to Equity (2023 - 2025)

Historic Debt to Equity for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to $2.71.

  • Inhibrx Biosciences' Debt to Equity changed N/A to $2.71 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.71, marking a year-over-year change of. This contributed to the annual value of $4.76 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Inhibrx Biosciences reported Debt to Equity of $2.71 as of Q3 2025.
  • In the past 5 years, Inhibrx Biosciences' Debt to Equity registered a high of $4.76 during Q4 2023, and its lowest value of $1.04 during Q1 2025.